Haleon (HLN) Stock Price, News & Analysis

+0.07 (+0.84%)
(As of 10:15 AM ET)
Today's Range
50-Day Range
52-Week Range
521,351 shs
Average Volume
5.43 million shs
Market Capitalization
$38.49 billion
P/E Ratio
Dividend Yield
Price Target

Haleon MarketRank™ Stock Analysis

Analyst Rating
Short Interest
0.55% of Float Sold Short
Dividend Strength
Based on Four Factors
News Sentiment
0.68mentions of Haleon in the last 14 days
Based on 4 Articles This Week
Insider Trading
Proj. Earnings Growth
From $0.47 to $0.51 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.76 out of 5 stars

Medical Sector

609th out of 910 stocks

Toilet Preparations Industry

11th out of 12 stocks

HLN stock logo

About Haleon Stock (NYSE:HLN)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

HLN Stock Price History

HLN Stock News Headlines

Haleon (NYSE:HLN) Now Covered by HSBC
Stocks Making Big Moves Today
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Pfizer Plans To Sell About 630 Mln Haleon Shares
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Haleon plc (HLN) Q4 2023 Earnings Call Transcript
Haleon plc 2023 Q4 - Results - Earnings Call Presentation
Zoetis Inc. (ZTS)
1 Pharma Stock to Buy Near 52-Week Highs
GSK to sell 3.2% stake in spin-off Haleon
See More Headlines
Receive HLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/16 Dividend
Next Earnings (Estimated)
Dividend Payable
Fiscal Year End

Industry, Sector and Symbol

Toilet preparations
Year Founded


Net Income
$1.30 billion
Pretax Margin


Sales & Book Value

Annual Sales
$11.30 billion
Cash Flow
$0.37 per share
Book Value
$4.51 per share


Outstanding Shares
Free Float
Market Cap
$38.10 billion
Not Optionable
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Brian James McNamara (Age 58)
    CEO & Executive Director
    Comp: $4.19M
  • Mr. Tobias Hannes Hestler (Age 52)
    CFO & Executive Director
    Comp: $2.33M
  • Ms. Sonya Ghobrial (Age 50)
    Head of Investor Relations
  • Ms. Tamara Rogers (Age 54)
    Chief Marketing Officer
  • Ms. Mairead Nayager (Age 49)
    Chief Human Resources Officer
  • Mr. Filippo Lanzi
    President of EMEA & LatAm
  • Mr. Keith Choy (Age 55)
    President of Asia Pacific
  • Ms. Lisa Paley (Age 57)
    President of North America
  • Mr. Franck Riot (Age 56)
    Chief R&D Officer
  • Mr. Bjorn Timelin
    Head of Strategy

Should I Buy Haleon Stock? HLN Pros and Cons Explained


Here are some ways that investors could benefit from investing in Haleon plc:

  • Haleon plc has shown consistent growth in its stock price, trading at $8.43 recently, with a market capitalization of $38.92 billion.
  • The company has a diverse product portfolio, including consumer healthcare products in various regions globally, providing revenue stability.
  • Recent institutional investments from reputable firms like Wellington Management Group LLP and Douglas Lane & Associates LLC indicate confidence in Haleon's future prospects.
  • Haleon plc has a low debt-to-equity ratio of 0.53, indicating a healthy financial structure and lower risk.
  • The company's dividend payout ratio of 75.00% suggests a commitment to rewarding shareholders with consistent dividends.


Investors should be bearish about investing in Haleon plc for these reasons:

  • The stock price of Haleon plc has shown minimal growth, with fluctuations around the $8 range, potentially limiting short-term capital gains.
  • Despite recent institutional investments, increased competition in the consumer healthcare industry could impact Haleon's market share and profitability.
  • The company's P/E ratio of 30.14 suggests the stock may be overvalued compared to industry peers, posing a risk of a price correction.
  • Haleon plc's P/E/G ratio of 2.17 indicates a higher valuation relative to its earnings growth rate, potentially signaling an inflated stock price.
  • Investors should consider the company's beta of 0.30, indicating lower volatility compared to the market average, which may limit potential returns in highly volatile market conditions.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, April 10, 2024. Please send any questions or comments about these Haleon pros and cons to contact@marketbeat.com.

HLN Stock Analysis - Frequently Asked Questions

Should I buy or sell Haleon stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" HLN shares.
View HLN analyst ratings
or view top-rated stocks.

How have HLN shares performed in 2024?

Haleon's stock was trading at $8.23 at the start of the year. Since then, HLN stock has increased by 1.4% and is now trading at $8.3450.
View the best growth stocks for 2024 here

Are investors shorting Haleon?

Haleon saw a increase in short interest in March. As of March 31st, there was short interest totaling 25,360,000 shares, an increase of 21.9% from the March 15th total of 20,810,000 shares. Based on an average daily volume of 5,650,000 shares, the short-interest ratio is presently 4.5 days. Approximately 0.6% of the shares of the stock are short sold.
View Haleon's Short Interest

When is Haleon's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our HLN earnings forecast

How often does Haleon pay dividends? What is the dividend yield for Haleon?

Haleon declared a semi-annual dividend on Thursday, February 29th. Investors of record on Friday, March 15th will be given a dividend of $0.1064 per share on Thursday, May 16th. This represents a yield of 1.8%. The ex-dividend date is Thursday, March 14th.
Read our dividend analysis for HLN

Is Haleon a good dividend stock?

Haleon (NYSE:HLN) pays an annual dividend of $0.21 per share and currently has a dividend yield of 2.59%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 75.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HLN will have a dividend payout ratio of 41.18% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HLN.

What ETFs hold Haleon's stock?
Who are Haleon's major shareholders?

Haleon's stock is owned by a number of institutional and retail investors. Top institutional investors include Douglas Lane & Associates LLC (0.18%), Raymond James & Associates (0.08%), Norden Group LLC (0.01%), JTC Employer Solutions Trustee Ltd (0.01%), First Hawaiian Bank (0.01%) and Keystone Financial Planning Inc. (0.01%).

How do I buy shares of Haleon?

Shares of HLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:HLN) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners